Nsgene
Records under this name other than patents Nsgene holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Nsgene
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,364,427 | Implantable Therapy System for Treating a Living Being with an Active Factor Formerly held Lapsed on the fee record Ended Jun 14, 2024 · High confidence | Lapsed on the fee record | Ended Jun 14, 2024 | High confidence |
| US 8,501,467 | Cultures of GFAP+ nestin+ cells that differentiate to neurons Formerly held Lapsed on the fee record Ended Aug 6, 2021 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2021 | USPTO record |
| US 7,651,853 | Cultures of GFAP+ nestin+ cells that differentiate to neurons Formerly held Term ended Term ended Dec 3, 2020 · USPTO record | Term ended | Term ended Dec 3, 2020 | USPTO record |